BGI Genomics Co., Ltd.

¥38.39As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300676Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (3.63%)
Div yield —
ROE (6.34%)
Diagnostics & Research
Beta (5Y) 0.76
PE TTM —
TSR TTM (21.97%)
Mkt cap ¥14.74B
ROIC (7.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥48
25.70%
13.22%
Hold 8|2|6|10|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.80
0.85
0.82
0.91
5.55%
6.94%
(0.36%)
14.70%
Revenue¥B
1.423
1.452
1.410
1.393
4.74%
2.43%
0.39%
0.59%
Peers (US$2.209B)
Cap (US$)
PE
1.960B
47.34x
1.125B
30.08x
2.179B
—
Capital
TTM
5Y
10Y
Leveragex
0.822
(0.016)
(0.019)
EBIT/Intx
0.271
0.203
0.223
Own earn%
(139.11)
(243.56)
(222.86)
Sh yield%
44.65
18.57
19.04
Owners
Insiders/Inst%
5.91
26.58
Short interest%
1.85
SBC / revenue%
1.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
28–41
$1 testx
0.0
Incr. ROIC%
4